Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.Journal of Surgical Research.  239:44-51. 2019
2018 Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.Cancer Research.  78:5144-5154. 2018
2018 Adjuvant anti-angiogenic therapy enhances chemotherapeutic uptake in a murine model of head and neck cancer.Journal of Drug Targeting.  1-8. 2018
2018 Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer.Surgical Oncology.  27:225-230. 2018
2018 Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma.Journal of Surgical Oncology.  117:1179-1187. 2018
2018 Recommendations for reporting on emerging optical imaging agents to promote clinical approval.Theranostics.  8:5336-5347. 2018
2018 Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.Theranostics.  8:2488-2495. 2018
2017 Characterizing the detection threshold for optical imaging in surgical oncology.Journal of Surgical Oncology.  116:898-906. 2017
2017 Fluorescence Imaging for Cancer Screening and Surveillance.Clinical Positron Imaging.  19:645-655. 2017
2017 T1-Enhanced MRI-visible nanoclusters for imaging-guided drug delivery.Nanoscale.  9:11785-11792. 2017
2017 Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.Clinical Cancer Research.  23:4744-4752. 2017
2017 Beyond the margins: real-time detection of cancer using targeted fluorophores.Nature Reviews Clinical Oncology.  14:347-364. 2017
2017 Laser-Assisted Indocyanine Green Dye Angiography for Postoperative Fistulas After Salvage Laryngectomy.JAMA Otolaryngology-Head and Neck Surgery.  143:775-781. 2017
2017 Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection.Cancer Research.  77:2197-2206. 2017
2017 Characterizing the Utility and Limitations of Repurposing an Open-Field Optical Imaging Device for Fluorescence-Guided Surgery in Head and Neck Cancer Patients.Journal of Nuclear Medicine.  58:246-251. 2017
2016 Oncologic Procedures Amenable to Fluorescence-guided Surgery.Annals of Surgery.  266:36-47. 2016
2016 Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation.Clinical Positron Imaging.  19:610-616. 2016
2016 Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.Laryngoscope.  126:E387-E395. 2016
2016 Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.Cancer Medicine.  5:1526-1534. 2016
2016 Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques.Clinical Positron Imaging.  18:232-242. 2016
2016 Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment.Journal of Pathology: Clinical Research.  2:104-112. 2016
2016 On the horizon: Optical imaging for cutaneous squamous cell carcinoma.Head & neck surgery.  38 Suppl 1:E2204-E2213. 2016
2016 SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts.Molecular Cancer Therapeutics.  15:680-688. 2016
2016 Standardized model for predicting flap failure using indocyanine green dyeProgress in Biomedical Optics and Imaging - Proceedings of SPIE.  9696. 2016
2016 Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report.Journal of Nuclear Medicine.  57:144-150. 2016
2015 Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney InjuryClinical Positron Imaging.  17:786-792. 2015
2015 Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney Injury.Clinical Positron Imaging.  17:786-792. 2015
2015 Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.Clinical Cancer Research.  21:3658-3666. 2015
2015 A ratiometric threshold for determining presence of cancer during fluorescence-guided surgery.Journal of Surgical Oncology.  112:2-8. 2015
2015 Laparoscopic Fluorescent Visualization of the Ureter With Intravenous IRDye800CW.Journal- American Association of Gynecologic Laparoscopists.  22:799-806. 2015
2015 In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas.Scientific Reports.  5:10169. 2015
2015 IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques.Clinical Positron Imaging.  17:49-57. 2015
2015 Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502.Molecular Imaging.  14:7290201400040. 2015
2015 Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.British Journal of Neurosurgery.  29:850-858. 2015
2015 The status of contemporary image-guided modalities in oncologic surgery.Annals of Surgery.  261:46-55. 2015
2015 Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies.Cancer Biology and Therapy.  16:790-798. 2015
2014 A standardized light-emitting diode device for photoimmunotherapy.Journal of Nuclear Medicine.  55:1893-1898. 2014
2014 A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging.Gene Therapy.  21:897-902. 2014
2014 Antibody-based imaging strategies for cancer.Cancer and Metastasis Reviews.  33:809-822. 2014
2014 Volumetric contrast-enhanced ultrasound imaging of renal perfusion.Journal of Ultrasound in Medicine.  33:1427-1437. 2014
2014 Biodistribution of P-selectin targeted microbubbles.Journal of Drug Targeting.  22:387-394. 2014
2014 Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer.Ultrasound in Medicine and Biology.  40:755-764. 2014
2014 Breast cancer imaging using the near-infrared fluorescent agent, CLR1502.Molecular Imaging.  13. 2014
2013 Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model.Ultrasound in Medicine and Biology.  39:2374-2381. 2013
2013 Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma.Cell Growth and Differentiation.  11:349-359. 2013
2013 Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy.IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.  60:281-289. 2013
2013 An animal model allowing controlled receptor expression for molecular ultrasound imaging.Ultrasound in Medicine and Biology.  39:172-180. 2013
2012 Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles.Cancer Gene Therapy.  19:545-552. 2012
2012 Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma.Archives of Otolaryngology Head and Neck Surgery.  138:662-668. 2012
2012 Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer.Journal of Drug Targeting.  20:43-54. 2012
2011 Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.Cell Growth and Differentiation.  9:1008-1017. 2011
2011 Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents.Ultrasound in Medicine and Biology.  37:1306-1313. 2011
2011 A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.Journal of Ultrasound in Medicine.  30:921-931. 2011
2011 A genetic strategy for combined screening and localized imaging of breast cancer.Clinical Positron Imaging.  13:452-461. 2011
2010 Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks.Journal of Ultrasound in Medicine.  29:577-585. 2010
2009 Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.Cancer Biology and Therapy.  8:1109-1116. 2009
2008 Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging.Cancer Research.  68:8369-8376. 2008
2008 Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody.Radiology.  248:844-851. 2008
2008 Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity.Molecular Endocrinology -Baltimore-.  22:1427-1437. 2008
Specimen mapping in head and neck cancer using fluorescence imaging.Laryngoscope Investigative Otolaryngology.  2:447-452.

Chapter

Year Title Altmetric
2015 Translation of therapeutic antibodies for intraoperative fluorescence imaging.  25-33. 2015

Principal Investigator On

Investigator On

  • UAB-UCSD O'Brien Center For Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research - Core B  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2017 - 2021
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility  awarded by National Cancer Institute/NIH/DHHS 2017 - 2021
  • Phase 1, Open-Label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer during Surgical Procedures  awarded by Stanford University 2015 - 2020
  • Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures  awarded by Stanford University 2015 - 2020
  • Lumina III System for UAB Optical Imaging  awarded by NIH - OFFICE OF THE DIRECTOR 2016 - 2017
  • Research Training Program in Surgical Oncology  awarded by National Cancer Institute/NIH/DHHS 2012 - 2016
  • Private Grant  awarded by LICOR, INC. 2014 - 2015
  • A Specific Screening Strategy to Reduce Prostate Cancer Mortality  awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY 2012 - 2015
  • Imaging Guided Surgery using Fluorescently Labeled Cetuximab  awarded by National Cancer Institute/NIH/DHHS 2014 - 2015
  • Education And Training

  • Bachelor of Science or Mathematics, University of Alabama at Birmingham
  • Doctor of Philosophy in Physiology, Pathology and Related Sciences, University of Alabama at Birmingham
  • Full Name

  • Jason Warram
  • Blazerid

  • mojack